No evidence found linking anti-nausea drug ondansetron to birth defects when used for Hyperemesis Gravidarum (HG)

resize_shutterstock_478045810Women suffering from extreme morning sickness often take Zofran (ondansetron) to combat their debilitating nausea and vomiting. However, two studies have found that the drug may increase risk of heart defects and cleft palate in children exposed in utero1.

Ondansetron is a serotonin 5-HT3 receptor antagonist which is […]

By | October 22nd, 2016|Blog, Pharmacy|0 Comments

FDA MedWatch Report GlucaGen HypoKit (glucagon [rDNA origin] for injection) recalled due to detached needles on syringe

resize_shutterstock_482965870Certain batches of GlucaGen HypoKit (glucagon [rDNA origin] for injection) by Novo Nordisk Inc. are being recalled due to some units containing syringes where the needles have been detached. Novo Nordisk Inc. is recalling six batches of the GlucaGen HypoKit in the U.S. due to two customer […]

By | October 13th, 2016|Blog, Pharmacy|0 Comments

Ohio Northern Provides Invaluable Healthcare Services to Residents of Hardin County in Ohio through Program Developed by College of Pharmacy

PCI_Staff Images_ERA










Watch Ernest Anderson, M.S., FASHP, a senior consultant with Pharmacy Consulting International (PCI) interview Dr. Steve Martin, Dean of the College of Pharmacy at Ohio Northern University as Dr. Martin discusses the unique primary care outreach program that […]

By | October 7th, 2016|Blog, Pharmacy|0 Comments

FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning

resize_shutterstock_8891356A U.S. Food and Drug Administration (FDA) review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects, including slowed or difficult breathing and deaths. Opioids are used to […]

By | September 27th, 2016|Blog, Pharmacy|0 Comments

Abuse deterrent formulations ofprescription opioid analgesic opioids

resize_shutterstock_462750346Pain affects more patients in the United States than diabetes, heart disease and cancer combined. Chronic pain in particular impacts over 100 million Americans. The burden of pain is high, both for the individual patient and society, and the combined annual cost of health care and decreased […]

By | September 20th, 2016|Blog, Pharmacy|0 Comments

FDA OKs Biosimilar to Etanercept (Enbrel ®) for Inflammatory Diseases

resizeshutterstock_426077551The US Food and Drug Administration (FDA) today approved etanercept-szzs (Erelzi ®, Sandoz), a biosimilar to etanercept (Enbrel ®, Amgen) for rheumatoid arthritis and other inflammatory diseases. The FDA Advisory Committee voted unanimously in July to recommend approval of the etanercept biosimilarand yesterday the FDA granted approval […]

By | September 13th, 2016|Blog, Pharmacy|0 Comments

Prescription Drug Misuse in America Diagnostic Insights in the Continuing Drug Epidemic Battle

shutterstock_56842843-Converted-300x226The 2016 Prescription Drug Monitoring Report from Quest Diagnostics® Health Trends™, the medical informatics unit of Quest Diagnostics, examines patterns and trends observed from prescription drug testing data performed by Quest laboratories in 2015. The prescription drug monitoring services of Quest test for commonly prescribed drugs, including […]

By | September 7th, 2016|Blog, Pharmacy|0 Comments

Risk of Hypoglycemia in Users of Sulphonylureas Compared With Metformin in Relation to Renal Function

resizeshutterstock_432264565-300x198In the 21st century, type 2 diabetes has reached epidemic proportions globally. It currently affects over 310 million people worldwide, and in 2014, 4.9 million deaths were attributable to diabetes related complications. Recently approved drugs with differing mechanisms of actions have provided multiple new options in the […]

By | August 30th, 2016|Blog, Pharmacy|0 Comments

FDA Approves Once-Daily VIEKIRA XR

viekiraOn July 26th, 2016 the US Food and Drug Administration (FDA) has approved VIEKIRA XR (AbbVie), a once-a-day version of Viekira Pak for chronic hepatitis C virus (HCV) genotype 1 infection. VIEKIRA XR is the first co-formulated three direct-acting antiviral (DAA) treatment for adult patients with GT1 […]

By | August 9th, 2016|Blog, Pharmacy|0 Comments

FDA MedWatch – Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication – Warnings Updated Due to Disabling Side Effects

Issues: July 26, 2016

FDA_LogoRecently the FDA has issued an alert and guidance for the use of fluoroquinolone antibacterial drugs for systemic use in disease states such as Acute Bacterial Sinusitis (ABS), Acute Exacerbations of Chronic Bronchitis (AECB) and Uncomplicated Urinary Tract Infections (uUTI). These new […]

By | July 27th, 2016|Blog, Pharmacy|0 Comments